Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
42 studies found for:    Acid Lipase Disease
Show Display Options
Rank Status Study
21 Completed Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease
Conditions: Obesity;   Nonalcoholic Fatty Liver Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
22 Completed
Has Results
Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects
Condition: HIV Infections
Intervention: Drug: Tipranavir
23 Completed
Has Results
Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine
Condition: Advanced Melanoma
Interventions: Drug: Ipilimumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Dacarbazine
24 Recruiting Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention:
25 Completed Comparison of MAG and Fish Oil Efficacy
Condition: Obesity
Interventions: Dietary Supplement: Fish oil enriched with EPA;   Dietary Supplement: MAG-EPA oil;   Drug: Orlistat
26 Terminated Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm Infants
Condition: Prevention of Growth Restriction
Interventions: Drug: rhBSSL (recombinant human bile-salt-stimulated lipase);   Drug: Placebo
27 Unknown  Lovaza Mechanisms of Action
Condition: Moderate Hypertriglyceridemia.
Intervention: Dietary Supplement: Omega 3 fatty acid (Lovaza)
28 Suspended A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Dietary Supplement: Conjugated Linoleic Acid;   Drug: Conjugated Linoleic Acid
29 Completed Following Lipectomy to Understand Adipose Tissue Re-accumulation
Conditions: Menopause;   Pre-menopause
Intervention: Procedure: Femoral lipectomy
30 Suspended Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies
Condition: Hyperlipoproteinemia Type I
Intervention:
31 Not yet recruiting Thiopurine Induced Pancreatitis in IBD Patients
Conditions: Pancreatitis;   Inflammatory Bowel Diseases
Intervention: Drug: Azathioprine
32 Completed
Has Results
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
33 Recruiting Baby Observational and Nutritional Study
Conditions: Cystic Fibrosis;   Growth Failure;   Exocrine Pancreatic Insufficiency
Interventions: Drug: Pancrelipase 3000 USP units of lipase;   Drug: Pancrelipase 750 USP units of lipase
34 Completed Substrate Cycling in Energy Metabolism
Conditions: Burns;   Insulin Resistance
Intervention: Drug: fenofibrate
35 Completed
Has Results
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
36 Active, not recruiting
Has Results
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GW433908;   Drug: ritonavir
37 Terminated
Has Results
A Study of LY2599506 in Patients With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: LY2599506
38 Terminated
Has Results
A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2599506;   Drug: Glyburide;   Drug: Placebo
39 Completed Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function
Conditions: Diabetes Mellitus, Type 2;   Cardiomyopathy, Dilated
Interventions: Drug: Acipimox;   Drug: Cellulosum Mycrocryst
40 Completed Comparative Effects of 2 Diets in Veterans With the Metabolic Syndrome
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: MUFA MOVE! (Monounsaturated fatty enriched diet);   Dietary Supplement: PUFA MOVE! (Polyunsaturated fatty acid enriched diet)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years